Advertisement
Advertisement
BRNS
Barinthus Biotherapeutics plc - ADR
0.67
USDSponsored
0.00
0.00%
May 08, 16:00 UTC -4
Closed
After-Market
0.65
-0.02
-3.13%
BRNS Earnings Reports
Positive Surprise Ratio
BRNS beat 14 of 21 last estimates.
67%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.28
Implied change from Q1 26 (Revenue/ EPS)
--
/+100.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/-46.15%
Barinthus Biotherapeutics plc - ADR earnings per share and revenue
On Apr 30, 2026, BRNS reported earnings of -0.14 USD per share (EPS) for Q1 26, beating the estimate of -0.28 USD, resulting in a 50.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.35% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an increase of 100.00% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Barinthus Biotherapeutics plc - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Barinthus Biotherapeutics plc - ADR reported EPS of -$0.14, beating estimates by 50.98%, and revenue of --, 0% as expectations.
How did the market react to Barinthus Biotherapeutics plc - ADR's Q1 2026 earnings?
The stock price moved up 8.35%, changed from $0.60 before the earnings release to $0.65 the day after.
When is Barinthus Biotherapeutics plc - ADR expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Barinthus Biotherapeutics plc - ADR's next earnings report?
Based on 4
analysts, Barinthus Biotherapeutics plc - ADR is expected to report EPS of -$0.28 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement